Aung M. Tun, M.D. – FDA Inspection, Jan 24, 2025

Record Details

This FDA Inspection record concerns Aung M. Tun, M.D., with an inspection on January 24, 2025, issued by the Kansas City District Office, covering human drugs.

Company: Aung M. Tun, M.D.
Inspection Date: January 24, 2025
Product Type: Human Drugs
Office: Kansas City District Office
Person: Carmen Y. Fisher (FDA Associated Person)

View Company Profile

ID · 11c81ad8-8193-4efd-a58d-d0ee87852ce1

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number: 1259324
FDA center: Human Drugs
Project area: Bioresearch Monitoring: Human Drugs
Outcome: Form 483 issued

FDA Citations

21 CFR 312.60FD-1572, protocol compliance

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Aung M. Tun, M.D.

FDA Inspection

Aung M. Tun, M.D.January 24, 2025